A 28-day repeated dose toxicity study of ultraviolet absorber 2-(2′-hydroxy-3′,5′-di-tert-butylphenyl) benzotriazole in rats

Drug and Chemical Toxicology

Volumn 30, Issue 4, 2007, Pages 327-341

  Hirata Koizumi, Mutsuko ^a   Watari, Nobuaki ^b   Mukai, Daisuke ^b   Imai, Toshio ^a   Hirose, Akihiko ^a   Kamata, Eiichi ^a   Ema, Makoto ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b An Pyo Center   (Japan)

Author keywords

Benzotriazole; Gender related difference; Rat; Repeated dose toxicity; UV absorber

Indexed keywords

2 (2' HYDROXY 3',5' DI TERTBUTYLPHENYL)BENZOTRIAZOLE; BENZOTRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOPHIL; BILE DUCT; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; HEART MUSCLE; HEMATOCRIT; HISTOPATHOLOGIC SKIN REACTION; KIDNEY TUBULE EPITHELIUM; LIGHT ABSORPTION; LIVER CELL; LIVER HYPERTROPHY; MALE; NONHUMAN; RAT; SEX DIFFERENCE; SPLEEN; THYROID GLAND; ULTRAVIOLET RADIATION;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; FEMALE; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PLASTICS; RATS; RATS, INBRED STRAINS; SEX FACTORS; TOXICITY TESTS, CHRONIC; TRIAZOLES; ULTRAVIOLET RAYS;

RATTUS; ZEA MAYS;

EID: 35348900707     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540701522254     Document Type: Article

References (20)

1. Bartlett, M. S. (1937). Properties of sufficiency and statistical tests. Proc. R. Soc. Lond. Ser. A 160:268-282.
2. Commerce Online (2006). Product Keywords on Wujiang Dongfeng Chemical Co., Ltd. Available at http://www.commerce.com.tw/company_inside.php?ID= C0013309.
3. Dunnett, C. W. (1964). New tables for multiple comparisons with a control. Biometrics 20:482-491.
4. EA, MHW and MITI (Environment Agency, Ministry of Health and Welfare, and Ministry of International Trade and Industry of Japan) (1986). Partial Amendment of the Testing Methods for New Chemical Substances. Planning and Coordination Bureau, Environment Agency No. 700, Pharmaceutical Affairs Bureau, Ministry of Health and Welfare No.1039 and Basic Industries Bureaus, Ministry of International Trade and Industry No. 1014 (dated December 5, 1986).
5. EA, MHW and MITI (Environment Agency, Ministry of Health and Welfare, and Ministry of International Trade and Industry of Japan) (2000). Testing Facility Provided in the Article 4 in the Ordinance Prescribing Test Relating to New Chemical Substances and Toxicity Research of Designated Chemical Substances'. Planning and Coordination Bureau, Environment Agency No.41 and Environmental Health Bureau, Ministry of Health and Welfare No. 268 (dated March 1, 2000), and Basic Industries Bureaus, Ministry of International Trade and Industry No. 1 (dated February 14 2000).
6. Fisher, R. A. (1973). Statistical Methods of Research Workers, 14th ed. New York: Hapner Publishing, p. 6.
7. Fletcher, C. V., Acosta, E. P., Strykowski, J. M. (1994). Gender differences in human pharmacokinetics and pharmacodynamics. J. Adolesc. Health 15:619-629.
8. Gad, S. C. (2006). Metabolism. In: Gad, S. C., ed. Animal Models in Toxicology, 2nd ed. Boca Raton, FL: CRC Press, Taylor & Francis Group, pp. 217-247.
9. Glaister, J. R. (1992). Histopathology of target organs - Cardiovascular: In: Principles of Toxicological Pathology (Japanese version supervised by Takahashi, M.). Tokyo: Soft Science Inc., pp. 135-142.
10. Harris, R. Z., Benet, L. Z., Schwartz, J. B. (1995). Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50:222-239.
11. Knuckles, M. E., Inyang, F., Ramesh, A. (2004). Acute and subchronic oral toxicity of fluoranthene in F-344 rats. Ecotoxicol. Environ. Saf. 59:102-108.
12. METI (Ministry of Economy, Trade and Industry of Japan) (2006). 2-(2H-1,2,3-Benzotriazole-2-yl)-4,6-di-tert-butylphenol. Document distributed in Committee on Safety of Chemical Substances, Chemical Substances Council, 30 June 2006. Available at http://www.meti.go.jp/committee/materials/ g60705aj.html.
13. MHLW (Ministry of Health, Labour and Welfare, Japan) (2003). 2-(2′-Hydroxy-3′,5′-detert-butylphenyl)benzotriazole. In: Toxicity Testing Reports of Environmental Chemicals (Ministry of Health, Labor and Welfare ed.), Vol. 10. Tokyo: Chemicals Investigation Promoting Council, pp. 215-247.
14. Morris, M. E., Lee, H. J., Predko, L. M. (2003). Gender differences in the membrane transport of endogenous and exogenous compounds. Pharmacol. Rev. 55:229-240.
15. OECD (Organization for Economic Co-operation and Development) (1998). OECD Principles on Good Laboratory Practice (as revised in 1997). OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring, No. 1. Paris: OECD.
16. Steel, R. D. (1959). A multiple comparison rank sum test: treatment versus control. Biometrics 15:560-572.
17. Tenkazai.com (2006). Market trend of Resin additives "Light stabilizer." Available at http://www.tenkazai.com/market.html.
18. U.S. EPA (2001). Robust Summaries & Test Plans: Phenolic Benzotriazoles Category, High Production Volume (HPV) Program, Available at http://www.epa.gov/chemrtk/ pubs/summaries/phenbenz/c13266tc.htm.
19. Wang, R. H., Schorer-Apelbaum, D., Weinstock, M. (2001). Testosterone mediates sex difference in hypothermia and cholinesterase inhibition by rivastigmine. Eur. J. Pharmacol. 433:73-79.
20. Waxman, D. J., Chang, T. K. (2005). Hormonal regulation of liver cytochrome P450 enzymes. In: Ortiz de Montellano, P. R., ed. Cytochrome P450 - Structure, Mechanism, and Biochemistry, 3rd ed., New York: Kluwer Academic/ Plenum, pp. 347-376.